Lauren Legrand, APRN
Gerontology · Glasgow, KYNPI 1851938807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,608 and has fallen 53.2% since, to $753 in 2025. Among gerontology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$554
- E.r. Squibb & Sons, L.L.C.$443
- Pfizer$379
- Amgen$327
- Novartis$315
- Takeda Pharmaceuticals U.S.A., Inc.$315
- plus $3K from 38 others
What the payments were for
- Food & beverage$5,255100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,281 in reported general payments places this provider in the 95th percentile of 84 gerontology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $993 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Glasgow
- Spencer GadlageLouisville$13K
- Devan CostelleLouisville$12K
- Dustin ThompsonPaducah$7K
- Bonny WillardBowling Green$5K
- Todd HellmichAshland$4K
- Brandi ScottHopkinsville$4K
- Lisa SpencerAshland$4K
- Emily CorsentinoLouisville$3K
- Ashley KirkBowling Green$3K
- Jamie PowersBowling Green$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.